International Journal for Advanced Review and Research in Pharmacy (IJARRP)
ISSN: 2349-1329
ISSN: 2349-1329
Ethics
IJARRP - Policies on Ethics, Conflict of Interest, Human and Animal Rights, and Informed Consent
Ethics
The publication of an article in a peer-reviewed journal is an essential building block in the development of a coherent and respected network of knowledge. It is a direct reflection of the quality of the work of the authors and the institutions that support them. Peer-reviewed articles support and embody the scientific method. It is therefore important to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editor, the peer reviewer, the publisher and the society of society-owned or sponsored journals.
Conflict of Interest
Authors are required to disclose all sources of institutional, private and corporate financial support for their study. Donors of materials (for free or at a discount from current rates) should be named in the source of funding and their location (town, state/county, country) included.Other donors will be identified in the text. If no funding has been available other than that of the author's institution, this should be specified upon submission. Authors are also required to disclose any potential conflict of interest. These include financial interests (for example patent,ownership, stock ownership, consultancies, speaker's fee,) or provision of study materials by their manufacturer for free or at a discount from current rates. Author's conflict of interest (orinformation specifying the absence of conflicts of interest) and the sources of funding for the research will be published under a separate heading entitled "Conflict of Interest and Sources of Funding Statement". Any experiments involving animals must be demonstrated to be ethically acceptable and where relevant conform to national guidelines for animal usage in research.
Human and Animal Rights
IJARRP encourages authors submitting manuscripts reporting from a clinical trial to register the trials registries & bear a clinical trial registration number and name of the trial. Authors must state that the protocol for the research project has been approved by a suitably constituted Ethics Committee of the institution within which the work was undertaken and that it conforms to the provisions of the Declaration of Helsinki. The Journal retains the right to reject any manuscript on the basis of unethical conduct of either human or animal studies. All investigations on human subjects must include a statement that the subject gave informed consent. Patient anonymity should be preserved. Photographs need to be cropped sufficiently to prevent human subjects being recognized or an eye bar should be used.
Reports of randomized clinical trials should present information on all major study elements,including the protocol, assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding), based on the CONSORT statement (Moher D, Schulz KF, Altman DG: The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials.
Consent for Identifying Information if any identifying information is included in any part of the manuscript, you must obtain a written, informed consent from the patient and submit a copy of the document to the Editorial Office of IJARRP.
All rights reserved.
Copyright © 2015 IJARRP
Copyright © 2015 IJARRP
Publications by IJARRP is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.Based on a work at IJARRP.Permissions beyond the scope of this license may be available at http://www.ijarrp.com/permissions.php.